Suchergebnisse - "Henry, Brandon M"

PubPharm (6)

1

Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Salvagno, G. | Henry, B. | Pighi, L. | +3

2

COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant : a light at the end of the tunnel?

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von Mattiuzzi, C. | Henry, B. | Lippi, G.

3

Updated picture of SARS-CoV-2 variants and mutations

enthalten in: Diagnosis (Berlin, Germany) | 2021

von Lippi, G. | Mattiuzzi, C. | Henry, B.

4

The strength of association between pre-and post-booster BNT162b2 anti-SARS-CoV-2 antibodies levels depends on the immunoassay

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021

von Salvagno, G. | Henry, B. | Lippi, G.

5

Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay

enthalten in: Clinical chemistry and laboratory medicine | 2021

von Salvagno, G. | Henry, B. | Pighi, L. | +3

CommentOn: Clin Chem Lab Med. 2021 Apr 14;59(8):1444-1452. - PMID 33855843

6

Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers

enthalten in: The Journal of infection | 2021

von Salvagno, G. | Henry, B. | Pighi, L. | +3

CommentOn: J Infect. 2021 Jun 20;:null. - PMID 34161817

1
[1]